• Text size
  • Send this article to a friend
  • Print this article

GSK reveals job plan to swap India for Scotland Glaxo chief explains move to Scotland

DRUGS giant GlaxoSmithKline is transferring manufacturing processes from India to Scotland and also planning to invest "tens of millions" at its operation in Ayrshire.

progress: Glaxo chief executive Andrew Witty revealed plans for the company's site in Montrose.
progress: Glaxo chief executive Andrew Witty revealed plans for the company's site in Montrose.
Custom byline text: 
mark smith deputy business editor

Chief executive Andrew Witty, the plain-speaking Yorkshireman who leads the world’s third largest drugs company, said the apparently counter-intuitive move would see 1.5 tonnes of biomanufacturing to move from India to Montrose in Angus.